Who invested in Immunocore?
Immunocore's investors include Eli Lilly, Woodford Investment Management and Malin Corporation.
United Kingdom · Venture startup
One round we have observed, with the 3 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Funding summaryUpdated 26 Oct 2026
$320Mraised across 1 round since 2015, from 1 source
From a historical funding record
Immunocore's investors include Eli Lilly, Woodford Investment Management and Malin Corporation.
Immunocore has raised $320M across 1 round since 2015.
Immunocore's most recent round was a Venture of $320M in Jul 2015.
Its most recent round, $320M in Jul 2015, is also its largest on record.
Immunocore's first round on record, in Jul 2015, was backed by Eli Lilly, Woodford Investment Management and Malin Corporation.
Immunocore's latest named round is a Venture, in Jul 2015.
Immunocore is based in the United Kingdom.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.